ICICI Prudential Healthcare Fund
Akums Drugs and Pharmaceuticals Limited · NSE
16,04,863 sh · ₹131.36 Cr
ICICI Prudential Healthcare Fund
1.9% of their portfolio
₹131.36 Cr
16,04,863 sh
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
1.9% of their portfolio
₹128.59 Cr
19,53,248 sh
Nippon India Pharma Fund
1.2% of their portfolio
₹110.63 Cr
13,51,672 sh
ICICI Prudential ELSS Tax Saver Fund
0.6% of their portfolio
₹92.09 Cr
13,98,828 sh
ICICI Prudential Equity & Debt Fund
0.1% of their portfolio
₹63.79 Cr
10,23,743 sh
ICICI Prudential ELSS – Tax Saver Fund
0.3% of their portfolio
₹46.68 Cr
6,01,049 sh
ICICI Prudential ELSS -Tax Saver Fund
0.3% of their portfolio
₹46.68 Cr
6,01,049 sh
ICICI Prudential Multi-Asset Fund
0.0% of their portfolio
₹27.76 Cr
5,29,339 sh
Groww Mutual Fund (scheme IB18)
0.0% of their portfolio
₹5.03 L
614 sh
Groww Mutual Fund (scheme NI)
0.0% of their portfolio
₹4.05 L
615 sh
FIIs raised their stake +0.5pp QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
ICICI Prudential Healthcare Fund
Akums Drugs and Pharmaceuticals Limited · NSE
16,04,863 sh · ₹131.36 Cr
Groww Mutual Fund (scheme IB18)
Akums Drugs and Pharmaceuticals Limited · NSE
614 sh · ₹5.03 L
Nippon India Pharma Fund
Akums Drugs and Pharmaceuticals Limited · NSE
13,51,672 sh · ₹110.63 Cr
Groww Mutual Fund (scheme IB18)
Akums Drugs and Pharmaceuticals Limited · NSE
618 sh · ₹4.80 L
ICICI Prudential ELSS -Tax Saver Fund
Akums Drugs and Pharmaceuticals Limited · NSE
6,01,049 sh · ₹46.68 Cr
ICICI Prudential ELSS – Tax Saver Fund
Akums Drugs and Pharmaceuticals Limited · NSE
6,01,049 sh · ₹46.68 Cr
Nippon India Pharma Fund
Akums Drugs and Pharmaceuticals Limited · NSE
13,51,672 sh · ₹104.98 Cr
ICICI Prudential Healthcare Fund
Akums Drugs and Pharmaceuticals Limited · NSE
17,95,770 sh · ₹139.48 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
37 announcements on record for this company.
Promoter holding by quarter: Jun 2025 75.3%, Sep 2025 75.3%, Dec 2025 75.3%, Mar 2026 75.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— +0.2pp
FII holding by quarter: Jun 2025 4.2%, Sep 2025 2.3%, Dec 2025 1.1%, Mar 2026 1.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— −0.1pp
DII holding by quarter: Jun 2025 8.8%, Sep 2025 9.3%, Dec 2025 14.4%, Mar 2026 14.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— −0.3pp
MF holding by quarter: Jun 2025 6.7%, Sep 2025 6.4%, Dec 2025 11.2%, Mar 2026 10.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
ICICI Prudential ELSS Tax Saver Fund
Akums Drugs and Pharmaceuticals Limited · NSE
13,98,828 sh · ₹92.09 Cr
Nippon India Pharma Fund
Akums Drugs and Pharmaceuticals Limited · NSE
14,05,283 sh · ₹92.52 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 75.3%, Sep 2025 75.3%, Dec 2025 75.3%, Mar 2026 75.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— +0.2pp
FII holding by quarter: Jun 2025 4.2%, Sep 2025 2.3%, Dec 2025 1.1%, Mar 2026 1.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— −0.1pp
DII holding by quarter: Jun 2025 8.8%, Sep 2025 9.3%, Dec 2025 14.4%, Mar 2026 14.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— −0.3pp
MF holding by quarter: Jun 2025 6.7%, Sep 2025 6.4%, Dec 2025 11.2%, Mar 2026 10.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
37 announcements on record for this company.